European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

EMA multi-stakeholder workshop on psychedelics – Towards an EU regulatory framework, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 16 April 2024, 13:00 (CEST) to 17 April 2024, 16:00 (CEST)

Submitted by Anonymous (not verified) on 16 July 2024 - 16:03

EMA multi-stakeholder workshop on psychedelics – Towards an EU regulatory framework, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 16 April 2024, 13:00 (CEST) to 17 April 2024, 16:00 (CEST)

Human medicines European public assessment report (EPAR): Beyfortus, nirsevimab, Date of authorisation: 31/10/2022, Revision: 7, Status: Authorised

Submitted by Anonymous (not verified) on 16 July 2024 - 15:18

Human medicines European public assessment report (EPAR): Beyfortus, nirsevimab, Date of authorisation: 31/10/2022, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Elocta, efmoroctocog alfa, Date of authorisation: 18/11/2015, Revision: 13, Status: Authorised

Submitted by Anonymous (not verified) on 16 July 2024 - 15:14

Human medicines European public assessment report (EPAR): Elocta, efmoroctocog alfa, Date of authorisation: 18/11/2015, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Nucala, mepolizumab, Date of authorisation: 01/12/2015, Revision: 19, Status: Authorised

Submitted by Anonymous (not verified) on 16 July 2024 - 15:07

Human medicines European public assessment report (EPAR): Nucala, mepolizumab, Date of authorisation: 01/12/2015, Revision: 19, Status: Authorised

European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties joint meeting, European Medicines Agency, Amsterdam, the Netherlands, from 2 July 2024 to 3 July 2024

Submitted by Anonymous (not verified) on 16 July 2024 - 14:37

European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties joint meeting, European Medicines Agency, Amsterdam, the Netherlands, from 2 July 2024 to 3 July 2024

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More